This inventor holds 1 USPTO granted patent. Top assignee: Aarhus Universitet. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Kristian Mark Jacobsen: Innovator in Cancer Treatment
Introduction
Kristian Mark Jacobsen is a notable inventor based in Harlev J, Denmark. He has made significant contributions to the field of cancer treatment through his innovative research and development of macrocyclic compounds.
Latest Patents
Jacobsen holds a patent for "Macrocycles comprising a 4-amido-2,4-pentadienoate moiety for the treatment of hypoxic cancers." This patent describes macrocyclic compounds that include a 4-amido-2,4-pentadienoate (APD) moiety. The compounds are designed to exhibit toxicity that is selective to the hypoxic micro-environments often found in cancerous tissues. Therefore, these compounds are suitable for the treatment of hypoxic cancer cells. He has 1 patent to his name.
Career Highlights
Jacobsen is affiliated with Aarhus Universitet, where he continues to advance his research in cancer therapies. His work focuses on developing innovative solutions that target specific cancer cell environments, which is crucial for improving treatment efficacy.
Collaborations
Some of his notable coworkers include Thomas Bjørnskov Poulsen and Per Hjerrild. Their collaborative efforts contribute to the ongoing research and development in the field of cancer treatment.
Conclusion
Kristian Mark Jacobsen is a dedicated inventor whose work in developing targeted cancer therapies showcases his commitment to advancing medical science. His innovative approach has the potential to significantly impact the treatment of hypoxic cancers.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile